Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$10,563,764
+$975,148 QoQ
Shares Held
29,172
+7.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#531
of 3,140 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Soltis Investment Advisors LLC holds $50,374,735 across 12 Drug Manufacturers - General names. AMGN ranks #2 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
49,990 | $12,695,960 | |
| 2 | AMGN |
Amgen Inc
This page
|
29,172 | $10,563,764 | |
| 3 | ABBV |
AbbVie Inc.
|
35,875 | $9,027,585 | |
| 4 | LLY |
ELI LILLY & Co
|
5,809 | $6,967,489 | |
| 5 | MRK |
Merck & Co., Inc.
|
48,517 | $6,234,434 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,594 | $2,454,266 | |
| 7 | PFE |
Pfizer Inc
|
26,981 | $649,702 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,981 | $629,299 |
All Filings in AMGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,563,764 | 29,172 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $9,588,616 | 27,252 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $8,493,367 | 25,949 | Shares | Sole | 2026-04-02 | |
| 2025-09-30 | $7,027,344 | 24,902 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,181,299 | 18,557 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $5,564,283 | 17,860 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $607,812 | 2,332 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $765,570 | 2,376 | Shares | Sole | 2025-01-03 | |
| 2024-06-30 | $632,398 | 2,024 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $687,770 | 2,419 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $701,904 | 2,437 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $638,573 | 2,376 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $460,469 | 2,074 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $307,022 | 1,270 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $258,963 | 986 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $222,244 | 986 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $232,594 | 956 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $220,539 | 912 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $418,894 | 1,862 | Shares | Sole | 2022-02-09 | |
| 2021-06-30 | $264,712 | 1,086 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $930,549 | 3,740 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $538,472 | 2,342 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||